Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

NCT02255266 · Completed

Last updated 2026-05-28

This clinical trial studied how well the medication liraglutide works over time to help adults with type 2 diabetes lower their blood sugar levels in real-world settings.

Status Completed The study has finished.

Type Observational

Participants 1,788 people

Who can join all sexes

Timeline Started 2015-03 · est. completion 2015-11

Where 1 site · Italy

What this study is testing ClinicalTrials.gov NCT02255266 ↗

Description as written by the study sponsor.

This study is conducted in Europe. The aim of this study is to investigate Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in daily Practice.

Treatments tested

liraglutide Drug

No treatment given.

Main thing measured	Frequency of patients achieving HbA1c reduction of at least 1%-point
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02255266 ↗